Search

MINIREVIEW Multifunctional Micellar Nanomedicine for Cancer Therapy ELVIN BLANCO,* CHASE W. KESSINGER,* BARAN D. SUMER,� AND JINMING GAO*,1 *Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390; and �Department of Otolaryngology, Southwestern Medical School, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235 Polymeric micelles are supramolecular, core-shell nanoparticles

Remain up to date about educational opportunities covering a variety of research administration topics.

1 P(tBu)2 P(tBu)2 CuBr P Pd P P P PBu3 Pt H Et3P Cl PEt3 Ir S R3P H PR3 H S -S PF6 - Ir S R3P H PR3 H P P Pd PF6 - Pt H Et3P Cl PEt3 Py P P Ir S R3P H PR3 H PF6 - Pt H Et3P Py PEt3 Cl Fe Pt H Et3P Py PEt3 P P Cl- Organometallic Reaction Mechanisms Ligand association/dissociation + toluene insoluble (PBu3)nCuBr soluble + active catalyst for cross coupling = NOTE: No ox. state change Ligand Exchange: Associative - common for 16e- complexes

N um ber 24 | 2009 C hem C om m Pages 3477–3640 ISSN 1359-7345 1359-7345(2009)24;1-# www.rsc.org/chemcomm Number 24 | 28 June 2009 | Pages 3477–3640 Chemical Communications As featured in: See Takahiro Kawamoto, Sho Hirabayashi, Xun-Xiang Guo, Takahiro Nishimura and Tamio Hayashi, Chem. Commun., 2009, 3528. www.rsc.org/chemcomm Registered Charity Number 207890 Rhodium-catalyzed intermolecular asymmetric hydroalkoxylation and hydrosulfenylation of

Where does the secreted protein acidic and rich in cysteine (SPARC) protein originate? What leads to its expression? SPARC is secreted from cells. Virtually any cell can produce SPARC. In fact most cells that are adherent in tissue culture produce SPARC at a detectable level. Growth of cells in culture is stressful and SPARC is a protein that is often produced by cells under stress, thus the concept of it as a ‘culture shock’ protein was established. In tissues, cells that are

PAPER www.rsc.org/materials | Journal of Materials Chemistry A novel strategy for surface modification of superparamagnetic iron oxide nanoparticles for lung cancer imaging† Gang Huang,a Chunfu Zhang,ab Shunzi Li,ac Chalermchai Khemtong,a Su-Geun Yang,a Ruhai Tian,a John D. Minna,ad Kathlynn C. Brownac and Jinming Gao*a Received 9th February 2009, Accepted 24th April 2009 First published as an Advance Article on the web 29th May 2009 DOI: 10.1039/b902358e Superparamagnetic iron oxide (SPIO

Advanced Synthesis and Catalysis, 2006 Unless noted, class is 9:00-10:30, mon and wed, L4.14 Date Topic Lecturer 8-22 Intro to catalysis Ready 8-24 Organometallics: structure/reactivity-1 Ready 8-29 Organometallics: structure/reactivity-2 Ready 8-31 Kinetics and mech-1 Ready 9-5 Kinetics and mech-2 Ready 9-7 Kinetic resolutions Ready 9-12 Nonlinear effects Ready 9-14 Addns to pi bonds-1 Ready 9-19 Addns to pi bonds-2 Ready 9-21 Addns to pi bonds-3 Ready 9-26 Conjugate addition-1 Ready 9-28

http://www.tandfonline.com/idrt ISSN: 1061-186X (print), 1029-2330 (electronic) J Drug Target, 2015; 23(7–8): 672–680 ! 2015 Taylor & Francis. DOI: 10.3109/1061186X.2015.1073296 REVIEW ARTICLE Nanotechnology-enabled delivery of NQO1 bioactivatable drugs Xinpeng Ma*y, Zachary R. Moore*, Gang Huang, Xiumei Huang, David A. Boothman, and Jinming Gao Department of Pharmacology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA Abstract

Articles https://doi.org/10.1038/s41551-020-00675-9 1Department of Pharmacology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. 2Department of Pathology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. 3Department of Otolaryngology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. 4Howard Hughes

There are sample requirements for services provided by Sanger Sequencing Core, McDermott Center. Standard primers are provided.